• ForwardForward
  • PrintPrint
  • Find EmployeesFind Employees
  • Find CompetitorsFind Competitors

Nektar Therapeutics Inc.

NASDAQ: NKTR

150 Industrial Rd
San Carlos, California 94070
United States 
Website:  www.nektar.com
Phone:  (650) 631-3100
Fax:  (650) 354-0701
Nektar Therapeutics's profile was created using:
  • 2,583 online sources
-

Summary

Ranking: Russell 3000
Revenues:  $273 Million
Employees:  793

Description
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with the PEGylation and pulmonary drug development technology platforms. The PEGylation technology is a chemical process designed to improve the performance of the drug classes with the potential to improve solubility and stability, improve drug half-life, reduce immune responses to an active drug and improve the efficacy or safety of a molecule in certain instances. The pulmonary technology makes drugs inhaleable to deliver them to and through the lungs for both systemic and local lung applications.
(Source: 10-K)
Products & Services
drug delivery, differentiated therapeutics, inhalation device

-

Additional Resources

Find More Jobs

Job Openings

Sr. Clinical Research Associate
San Carlos , CA

Associate Director Regulatory Affairs
Huntsville , AL


View More Statistics

Site Statistics

Monthly Unique Visitors: 1,081
Site Rank: 981,654
Trust Rating: Neutral
Stats by Compete.com

News Archive
Nektar Therapeutics to Present at the UBS 2009 Global Life Sciences Conference in New York City.
PR Newswire; 9/18/2009
...PRNewswire-FirstCall/ -- Nektar Therapeutics is scheduled to present at...October 25, 2009. About Nektar Nektar Therapeutics is a biopharmaceutical company...Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 jruddock... ...more

Profiles Vivakor, Inc. & Nektar Therapeutics.
M2 Presswire; 9/21/2009
...Profiles Vivakor, Inc. & Nektar Therapeutics(C)1994-2009 M2 COMMUNICATIONS...Inc. (OTCBB: VIVK); Nektar Therapeutics (NASDAQ: NKTR) Stock Profiler...Nektar Therapeutics closed at $8.46 Friday... ...more

Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City.
PR Newswire; 7/31/2009
...PRNewswire-FirstCall/ -- Nektar Therapeutics is scheduled to present at...August 31, 2009. About Nektar Nektar Therapeutics is a biopharmaceutical company...Contacts: Jennifer Ruddock Nektar Therapeutics 650-631-4954 Susan Noonan... ...more

Powered By:

-

Key People

-

Competitors

About Thumbshots thumbnails

Copyright © 2010 Zoom Information Inc. All rights reserved.

BBeachHead-2009-12-03_RC001.1 OM12